448 related articles for article (PubMed ID: 35107865)
1. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
Fung BM; Lindor KD; Tabibian JH
World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
5. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
[TBL] [Abstract][Full Text] [Related]
6. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
Chascsa DM; Lindor KD
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.
Huang J; Li X; Hong J; Huang L; Jiang Q; Guo S; Rong Y; Guo G
Cancer Med; 2023 Jun; 12(12):13599-13609. PubMed ID: 37184160
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
10. Screening for malignancy in primary sclerosing cholangitis (PSC).
Khaderi SA; Sussman NL
Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
[TBL] [Abstract][Full Text] [Related]
11. Cancer surveillance in patients with primary sclerosing cholangitis.
Razumilava N; Gores GJ; Lindor KD
Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
[TBL] [Abstract][Full Text] [Related]
12. [Primary sclerosing cholangitis].
Boonstra K; Ponsioen CI; Rauws EA; Beuers U
Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
16. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort.
de Valle MB; Björnsson E; Lindkvist B
Liver Int; 2012 Mar; 32(3):441-8. PubMed ID: 22098097
[TBL] [Abstract][Full Text] [Related]
17. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
Yuan J; Han GH
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
Bonato G; Cristoferi L; Strazzabosco M; Fabris L
Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
[TBL] [Abstract][Full Text] [Related]
20. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
